Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15276 - 15300 of 15459 in total
HTPEP-001 is a novel peptide that works to inhibit the activation of transforming growth factor beta (TGF-β). It is being investigated for the treatment of fibrosis.
Investigational
Sacituzumab tirumotecan is a recombinant humanized IgG1 anti-TROP2 monoclonal antibody conjugated to a topoisomerase I inhibitor.
Investigational
Experimental
Experimental
Experimental
Experimental
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
Experimental
Experimental
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism...
Investigational
Matched Description: … of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and
Experimental
Doramapimod is a P38 MAP kinase inhibitor.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational
Displaying drugs 15276 - 15300 of 15459 in total